+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
In Vitro Lung Model Market - Global Forecast 2026-2032- Product Image
In Vitro Lung Model Market - Global Forecast 2026-2032- Product Image
New

In Vitro Lung Model Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 194 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5889471
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The in vitro lung model market is experiencing strong transformation, supported by increasing expectations for preclinical precision, reduced animal dependence, and the delivery of actionable translational insights. These performance drivers are reshaping procurement priorities from the research bench to commercial deployment.

Market Snapshot: In Vitro Lung Model Market Overview

The In Vitro Lung Model Market grew from USD 802.58 million in 2025 to USD 938.48 million in 2026, demonstrating robust momentum with a compound annual growth rate (CAGR) of 17.64% and a projected value of USD 2.50 billion by 2032. This substantial expansion is driven by the industry’s shift toward sophisticated research models that accurately reflect human lung biology. As organizations prioritize translational outcomes and regulatory readiness, demand for scalable, reproducible, and physiologically relevant in vitro systems spans multiple application domains, from drug discovery to personalized medicine and safety evaluation. Enhanced model fidelity is becoming non-negotiable for organizations working at the intersection of scientific research and regulatory compliance.

Scope & Segmentation: Platforms, Applications, and Regional Priorities

  • Model Types: 2D cell cultures, 3D organoids, lung-on-a-chip platforms, and precision-cut lung slices each address unique research needs, from rapid screening to studies that require complex tissue mimicry.
  • Application Areas: Disease modeling, drug development, toxicity testing, and personalized medicine all utilize distinct model configurations to improve predictive power and clinical relevance.
  • Cell Sources: Options include animal-derived cells, immortalized lines, primary human cells, and stem cell-derived constructs, providing a critical balance of scalability and translational value for varying project stages.
  • Technology Choices: Microfluidics, scaffold-based, and scaffold-free techniques impact both experimental throughput and the physiological accuracy required for dynamic studies.
  • Product Types: Instruments, kits, and reagents form the core of procurement strategies, influencing both capital investments and recurring operational expenses.
  • End Users: Stakeholders such as academic institutions, contract research organizations, pharmaceutical and biotech companies, and regulatory authorities drive model selection criteria and validation parameters.
  • Regions: Americas, EMEA, and Asia-Pacific shape market development, influenced by regulatory frameworks, research funding, and local manufacturing capacities. Regional infrastructure and collaborative ecosystems also determine supply chain efficiency and service availability.

Key Takeaways: Strategic Insights for Decision Makers

  • Model selection aligns closely with specific research objectives, requiring ongoing collaboration across scientific and operational teams to ensure relevant outcomes and robust validation.
  • 3D constructs and organ-on-a-chip systems improve physiological mimicry, supporting advanced disease modeling and responses in dynamic environments.
  • Ongoing strides in protocol standardization and computational analytics are enhancing cross-laboratory data comparability and regulatory confidence, enabling smoother integration into safety and efficacy studies.
  • Organizations are increasingly adopting integrated solutions that consolidate workflow steps, simplify procurement, and support scale-up as project needs evolve.
  • Service models that incorporate operator training and advanced data support are strengthening supplier differentiation and establishing long-term value streams for industry partners.
  • Emerging competitors are focusing on targeted technical improvements or specialized use cases, fostering a climate of rapid innovation and sector-specific collaboration.

Tariff Impact: Mitigating Trade and Supply Chain Challenges

Recent tariffs and shifting trade policies introduced in 2025 are prompting companies to reassess procurement and manufacturing strategies within the in vitro lung model market. Laboratories and suppliers are enhancing supply chain resilience by broadening their vendor portfolios, investing in local or regional production, and focusing on transparent sourcing processes. These measures address increased landed costs and potential supply disruptions, safeguarding timelines for critical research and development programs and reinforcing operational continuity in unpredictable geopolitical environments.

Methodology & Data Sources

This analysis draws on primary interviews with leaders in academia, clinical practice, and commercial research, combined with data from peer-reviewed publications, technical reports, and regulatory filings. Technical accuracy is ensured by robust cross-validation of model fidelity, reproducibility, and traceability metrics. The methodology supports both current market mapping and assessment of emerging risks and opportunities.

Why This Report Matters

  • Supports procurement and investment planning by analyzing segmentation, technology fit, and user needs across the in vitro lung model landscape.
  • Provides strategic recommendations for building commercial and operational resilience amid ongoing regulatory changes and global trade uncertainties.
  • Guides research, development, and supply teams toward solutions that align operational strategy with cutting-edge in vitro technologies.

Conclusion

As market dynamics accelerate, a comprehensive approach emphasizing model reliability, supply chain robustness, and regulatory foresight enables industry stakeholders to advance pulmonary R&D objectives while managing complexity and risk.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. In Vitro Lung Model Market, by Product Type
8.1. Instruments
8.2. Kits & Reagents
9. In Vitro Lung Model Market, by Model Type
9.1. 2D Cell Cultures
9.1.1. Cell Line Cultures
9.1.2. Primary Cell Cultures
9.2. 3D Organoids
9.2.1. Alveolar Organoids
9.2.2. Bronchial Organoids
9.3. Lung-On-A-Chip
9.4. Precision-Cut Lung Slices
10. In Vitro Lung Model Market, by Cell Source
10.1. Animal-Derived Cells
10.2. Cell Lines
10.3. Human-Derived Cells
10.3.1. Primary Cells
10.3.2. Stem Cell-Derived Cells
11. In Vitro Lung Model Market, by Technology
11.1. Microfluidics
11.1.1. Continuous Flow Systems
11.1.2. Droplet-Based Systems
11.2. Scaffold-Based Cultures
11.2.1. Natural Scaffolds
11.2.2. Synthetic Scaffolds
11.3. Scaffold-Free Cultures
11.3.1. Bioreactors
11.3.2. Hanging Drop
12. In Vitro Lung Model Market, by Application
12.1. Disease Modeling
12.2. Drug Discovery & Development
12.3. Personalized Medicine
12.4. Toxicity Testing
13. In Vitro Lung Model Market, by End Users
13.1. Academic & Research Institutes
13.2. CROs
13.3. Pharmaceutical & Biotechnology Companies
13.4. Regulatory Agencies
14. In Vitro Lung Model Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. In Vitro Lung Model Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. In Vitro Lung Model Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States In Vitro Lung Model Market
18. China In Vitro Lung Model Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. AlveoliX AG
19.6. Brainlab AG
19.7. Cn Bio Innovations Limited
19.8. Emulate, Inc.
19.9. Epithelix Sarl
19.10. Hologic, Inc.
19.11. Horizon Discovery Group plc
19.12. Insphero AG
19.13. Lonza Group AG
19.14. Mattek Corporation by Bico Group
19.15. McKesson Corporation
19.16. Merck KGaA
19.17. MICA Information Systems, Inc.
19.18. Mimetas B.V.
19.19. PromoCell GmbH
19.20. STEMCELL Technologies Inc.
19.21. Thermo Fisher Scientific Inc
19.22. Tissuse GmbH
19.23. Varian Medical Systems, Inc
List of Figures
FIGURE 1. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL IN VITRO LUNG MODEL MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL IN VITRO LUNG MODEL MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA IN VITRO LUNG MODEL MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY KITS & REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY KITS & REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY CELL LINE CULTURES, BY REGION, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY CELL LINE CULTURES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY CELL LINE CULTURES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PRIMARY CELL CULTURES, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PRIMARY CELL CULTURES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PRIMARY CELL CULTURES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY ALVEOLAR ORGANOIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY ALVEOLAR ORGANOIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY ALVEOLAR ORGANOIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY BRONCHIAL ORGANOIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY BRONCHIAL ORGANOIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY BRONCHIAL ORGANOIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY LUNG-ON-A-CHIP, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY LUNG-ON-A-CHIP, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY LUNG-ON-A-CHIP, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PRECISION-CUT LUNG SLICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PRECISION-CUT LUNG SLICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PRECISION-CUT LUNG SLICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY ANIMAL-DERIVED CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY ANIMAL-DERIVED CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY ANIMAL-DERIVED CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY CELL LINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY CELL LINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY CELL LINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PRIMARY CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PRIMARY CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PRIMARY CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY STEM CELL-DERIVED CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY STEM CELL-DERIVED CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY STEM CELL-DERIVED CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY CONTINUOUS FLOW SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY CONTINUOUS FLOW SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY CONTINUOUS FLOW SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY DROPLET-BASED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY DROPLET-BASED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY DROPLET-BASED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY NATURAL SCAFFOLDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY NATURAL SCAFFOLDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY NATURAL SCAFFOLDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY SYNTHETIC SCAFFOLDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY SYNTHETIC SCAFFOLDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY SYNTHETIC SCAFFOLDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY BIOREACTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY BIOREACTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY HANGING DROP, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY HANGING DROP, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY HANGING DROP, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY DISEASE MODELING, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY DISEASE MODELING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY DISEASE MODELING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PERSONALIZED MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PERSONALIZED MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY TOXICITY TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY TOXICITY TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY TOXICITY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY CROS, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY CROS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY CROS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY REGULATORY AGENCIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY REGULATORY AGENCIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY REGULATORY AGENCIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2032 (USD MILLION)
TABLE 118. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 119. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
TABLE 120. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2032 (USD MILLION)
TABLE 121. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2032 (USD MILLION)
TABLE 122. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 123. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2032 (USD MILLION)
TABLE 128. NORTH AMERICA IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2032 (USD MILLION)
TABLE 129. NORTH AMERICA IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2032 (USD MILLION)
TABLE 131. NORTH AMERICA IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 132. NORTH AMERICA IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2032 (USD MILLION)
TABLE 134. NORTH AMERICA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2032 (USD MILLION)
TABLE 135. NORTH AMERICA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 136. NORTH AMERICA IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. LATIN AMERICA IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 139. LATIN AMERICA IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 140. LATIN AMERICA IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2032 (USD MILLION)
TABLE 141. LATIN AMERICA IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2032 (USD MILLION)
TABLE 142. LATIN AMERICA IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 143. LATIN AMERICA IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2032 (USD MILLION)
TABLE 144. LATIN AMERICA IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 145. LATIN AMERICA IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
TABLE 146. LATIN AMERICA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2032 (USD MILLION)
TABLE 147. LATIN AMERICA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2032 (USD MILLION)
TABLE 148. LATIN AMERICA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2032 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2032 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2032 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2032 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2032 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 163. EUROPE IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 164. EUROPE IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 165. EUROPE IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 166. EUROPE IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2032 (USD MILLION)
TABLE 167. EUROPE IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2032 (USD MILLION)
TABLE 168. EUROPE IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 169. EUROPE IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2032 (USD MILLION)
TABLE 170. EUROPE IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 171. EUROPE IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
TABLE 172. EUROPE IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2032 (USD MILLION)
TABLE 173. EUROPE IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2032 (USD MILLION)
TABLE 174. EUROPE IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 175. EUROPE IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 176. MIDDLE EAST IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. MIDDLE EAST IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 178. MIDDLE EAST IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 179. MIDDLE EAST IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2032 (USD MILLION)
TABLE 180. MIDDLE EAST IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2032 (USD MILLION)
TABLE 181. MIDDLE EAST IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 182. MIDDLE EAST IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2032 (USD MILLION)
TABLE 183. MIDDLE EAST IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 184. MIDDLE EAST IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
TABLE 185. MIDDLE EAST IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2032 (USD MILLION)
TABLE 186. MIDDLE EAST IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2032 (USD MILLION)
TABLE 187. MIDDLE EAST IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 188. MIDDLE EAST IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 189. AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 191. AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 192. AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2032 (USD MILLION)
TABLE 193. AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2032 (USD MILLION)
TABLE 194. AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 195. AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2032 (USD MILLION)
TABLE 196. AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 197. AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
TABLE 198. AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2032 (USD MILLION)
TABLE 199. AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2032 (USD MILLION)
TABLE 200. AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 201. AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 202. ASIA-PACIFIC IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 203. ASIA-PACIFIC IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 204. ASIA-PACIFIC IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 205. ASIA-PACIFIC IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2032 (USD MILLION)
TABLE 206. ASIA-PACIFIC IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2032 (USD MILLION)
TABLE 207. ASIA-PACIFIC IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 208. ASIA-PACIFIC IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2032 (USD MILLION)
TABLE 209. ASIA-PACIFIC IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 210. ASIA-PACIFIC IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
TABLE 211. ASIA-PACIFIC IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2032 (USD MILLION)
TABLE 212. ASIA-PACIFIC IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2032 (USD MILLION)
TABLE 213. ASIA-PACIFIC IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 214. ASIA-PACIFIC IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 215. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 216. ASEAN IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. ASEAN IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 218. ASEAN IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 219. ASEAN IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2032 (USD MILLION)
TABLE 220. ASEAN IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2032 (USD MILLION)
TABLE 221. ASEAN IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 222. ASEAN IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2032 (USD MILLION)
TABLE 223. ASEAN IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 224. ASEAN IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
TABLE 225. ASEAN IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2032 (USD MILLION)
TABLE 226. ASEAN IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2032 (USD MILLION)
TABLE 227. ASEAN IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 228. ASEAN IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 229. GCC IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 230. GCC IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 231. GCC IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 232. GCC IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2032 (USD MILLION)
TABLE 233. GCC IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2032 (USD MILLION)
TABLE 234. GCC IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 235. GCC IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2032 (USD MILLION)
TABLE 236. GCC IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 237. GCC IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
TABLE 238. GCC IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2032 (USD MILLION)
TABLE 239. GCC IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2032 (USD MILLION)
TABLE 240. GCC IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 241. GCC IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 243. EUROPEAN UNION IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 244. EUROPEAN UNION IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 245. EUROPEAN UNION IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2032 (USD MILLION)
TABLE 246. EUROPEAN UNION IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2032 (USD MILLION)
TABLE 247. EUROPEAN UNION IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 248. EUROPEAN UNION IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2032 (USD MILLION)
TABLE 249. EUROPEAN UNION IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 250. EUROPEAN UNION IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
TABLE 251. EUROPEAN UNION IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2032 (USD MILLION)
TABLE 252. EUROPEAN UNION IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2032 (USD MILLION)
TABLE 253. EUROPEAN UNION IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 254. EUROPEAN UNION IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 255. BRICS IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 256. BRICS IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 257. BRICS IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 258. BRICS IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2032 (USD MILLION)
TABLE 259. BRICS IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2032 (USD MILLION)
TABLE 260. BRICS IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 261. BRICS IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2032 (USD MILLION)
TABLE 262. BRICS IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 263. BRICS IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
TABLE 264. BRICS IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2032 (USD MILLION)
TABLE 265. BRICS IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2032 (USD MILLION)
TABLE 266. BRICS IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 267. BRICS IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 268. G7 IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 269. G7 IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 270. G7 IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 271. G7 IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2032 (USD MILLION)
TABLE 272. G7 IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2032 (USD MILLION)
TABLE 273. G7 IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 274. G7 IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2032 (USD MILLION)
TABLE 275. G7 IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 276. G7 IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
TABLE 277. G7 IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2032 (USD MILLION)
TABLE 278. G7 IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2032 (USD MILLION)
TABLE 279. G7 IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 280. G7 IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 281. NATO IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 282. NATO IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 283. NATO IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 284. NATO IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2032 (USD MILLION)
TABLE 285. NATO IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2032 (USD MILLION)
TABLE 286. NATO IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 287. NATO IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2032 (USD MILLION)
TABLE 288. NATO IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 289. NATO IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
TABLE 290. NATO IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2032 (USD MILLION)
TABLE 291. NATO IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2032 (USD MILLION)
TABLE 292. NATO IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 293. NATO IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 294. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 295. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 296. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 297. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 298. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2032 (USD MILLION)
TABLE 299. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2032 (USD MILLION)
TABLE 300. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 301. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2032 (USD MILLION)
TABLE 302. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 303. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
TABLE 304. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2032 (USD MILLION)
TABLE 305. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2032 (USD MILLION)
TABLE 306. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 307. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 308. CHINA IN VITRO LUNG MODEL MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 309. CHINA IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 310. CHINA IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 311. CHINA IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2032 (USD MILLION)
TABLE 312. CHINA IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2032 (USD MILLION)
TABLE 313. CHINA IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 314. CHINA IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2032 (USD MILLION)
TABLE 315. CHINA IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 316. CHINA IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
TABLE 317. CHINA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2032 (USD MILLION)
TABLE 318. CHINA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2032 (USD MILLION)
TABLE 319. CHINA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 320. CHINA IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this In Vitro Lung Model market report include:
  • AlveoliX AG
  • Brainlab AG
  • Cn Bio Innovations Limited
  • Emulate, Inc.
  • Epithelix Sarl
  • Hologic, Inc.
  • Horizon Discovery Group plc
  • Insphero AG
  • Lonza Group AG
  • Mattek Corporation by Bico Group
  • McKesson Corporation
  • Merck KGaA
  • MICA Information Systems, Inc.
  • Mimetas B.V.
  • PromoCell GmbH
  • STEMCELL Technologies Inc.
  • Thermo Fisher Scientific Inc
  • Tissuse GmbH
  • Varian Medical Systems, Inc

Table Information

Report AttributeDetails
No. of Pages194
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 938.48 Million
Forecasted Market Value ( USD ) by 2032 $ 2500 Million
Compound Annual Growth Rate17.6%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

In Vitro Lung Model - Global Strategic Business Report - Product Image

In Vitro Lung Model - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
In-Vitro Lung Model Market Report 2025 - Product Image

In-Vitro Lung Model Market Report 2025

  • Report
  • 250 Pages
  • Global
From
In Vitro Lung Models Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, End User, and Geography - Product Image

In Vitro Lung Models Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, End User, and Geography

  • Report
  • 231 Pages
  • Global
From
In-Vitro Toxicology Testing Market - Global Forecast 2026-2032 - Product Image

In-Vitro Toxicology Testing Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
In Vitro Angiogenesis Assay Kit Market - Global Forecast 2025-2030 - Product Image

In Vitro Angiogenesis Assay Kit Market - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From

About the In Vitro Lung Model Market

The In Vitro Lung Model market is a subset of the In Vitro Diagnostics (IVD) industry. It is composed of products and services used to simulate the human lung in a laboratory setting. These models are used to study the effects of drugs, toxins, and other substances on the respiratory system. They are also used to develop new treatments and therapies for respiratory diseases. In Vitro Lung Models are typically composed of a combination of cell cultures, organoids, and 3D printed scaffolds. These models are used to study the effects of drugs, toxins, and other substances on the respiratory system. They are also used to develop new treatments and therapies for respiratory diseases. The In Vitro Lung Model market is highly competitive, with many companies offering a variety of products and services. Some of the major players in the market include Thermo Fisher Scientific, Merck KGaA, PromoCell, Lonza, and Corning. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.